Analytical challenges in sports drug testing
Analytical chemistry represents a central aspect of doping controls. Routine sports drug testing approaches are primarily designed to address the question whether a prohibited substance is present in a doping control sample and whether prohibited methods (for example, blood transfusion or sample manipulation) have been conducted by an athlete. As some athletes have availed themselves of the substantial breadth of research and development in the pharmaceutical arena, proactive and preventive measures are required such as the early implementation of new drug candidates and corresponding metabolites into routine doping control assays, even though these drug candidates are to date not approved for human use. Beyond this, analytical data are also cornerstones of investigations into atypical or adverse analytical findings, where the overall picture provides ample reason for follow-up studies. Such studies have been of most diverse nature, and tailored approaches have been required to probe hypotheses and scenarios reported by the involved parties concerning the plausibility and consistency of statements and (analytical) facts. In order to outline the variety of challenges that doping control laboratories are facing besides providing optimal detection capabilities and analytical comprehensiveness, selected case vignettes involving the follow-up of unconventional adverse analytical findings, urine sample manipulation, drug/food contamination issues, and unexpected biotransformation reactions are thematized.
KeywordsClenbuterol Proguanil Chlorazanil Manipulation Doping Mass spectrometry
The authors thank the Manfred-Donike-Institute for Doping Analysis (Cologne, Germany) and the Federal Ministry of the Interior of the Federal Republic of Germany (Bonn, Germany) for the support.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.WADA. The 2018 Prohibited List. Montreal: Wolrd Anti-Doping Agency; 2017 [cited 26.10.2017]. Available from: https://www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf.
- 2.Kidd B, Edelman R, Brownell S. Comparative analysis of doping scandals: Canada, Russia, and China. In: Wilson W, Derse E, editors. Doping in elite sport. Chamaign: Human Kinetics; 2001. p. 153–88.Google Scholar
- 6.Thevis M, Volmer DA. Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation. Eur J Mass Spectrom. 2017;23. https://doi.org/10.1177/1469066717731228.
- 8.McLaren R. The Independent Person 2nd Report: Richard McLaren; 2016 [cited 27.10.2017]. Available from: https://www.wada-ama.org/sites/default/files/resources/files/mclaren_report_part_ii_2.pdf.
- 10.Thevis M, Schänzer W. Detection of SARMs in doping control analysis. Mol Cell Endocrinol. 2017;in press; https://doi.org/10.1016/j.mce.2017.01.040.
- 15.Eichner D, Van Wagoner RM, Brenner M, Chou J, Leigh S, Wright LR, et al. Implementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls. Drug Test Anal. 2017; https://doi.org/10.1002/dta.2202.
- 16.Dib J, Mongongu C, Buisson C, Molina A, Schänzer W, Thuss U, et al. Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls. Drug Test Anal. 2017;9:61–7.CrossRefGoogle Scholar
- 18.CyclingNews. Kvasina positive for EPO stimulator at Fleche du Sud: CyclingNews; 2017 [cited 05–07-2017]. Available from: http://www.cyclingnews.com/news/kvasina-positive-for-epo-stimulator-at-fleche-du-sud/.
- 20.Reichel C, Gmeiner G, Thevis M. Antibody-based strategies for the detection of luspatercept (ACE-536) in human serum. Drug Test Anal. 2017; https://doi.org/10.1002/dta.2302.
- 21.WADA. World Anti-Doping Code. Montreal: World Anti-Doping Agency; 2015 [cited 12–04-2016]. Available from: https://wada-main-prod.s3.amazonaws.com/resources/files/wada-2015-world-anti-doping-code.pdf.
- 24.Parr MK, Blokland MH, Liebetrau F, Schmidt AH, Meijer T, Stanic M, et al. Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial—the potential of enantiomeric separation for doping control analysis. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017;34(4):525–35.CrossRefGoogle Scholar
- 26.USADA. U.S. Volleyball Athlete Alexandra Klineman Accepts Finding of No Fault for Anti-Doping Rule Violation Colorado Springs: U.S. Anti-Doping Agency; 2017 [cited 17–11-2017]. Available from: https://www.usada.org/alexandra-klineman-accepts-finding-no-fault/.
- 29.Geyer H, Mareck U, Schänzer W, Donike M, editors. The cologne protocol to follow up high testosterone/epitestosterone ratios. Recent advances in doping analysis. Cologne: Sport und Buch Strauss; 1997.Google Scholar